Guideline on plasma-derived medicinal products

We have adopted this International Scientific Guideline - EMA/CHMP/BWP/706271/2010

Last updated

17 January 2025

About this guideline

Overseas effective date: 1 February 2012

Replaces: CPMP/BWP/269/95 Rev 3

Categories: Biologicals | Active substance | Plasma-derived medicinal products

Where EU guidelines adopted in Australia include references to EU legislation (including EC Directives and Regulations), the requirements contained in the referenced EU legislation are not applicable to the evaluation of medicines by the TGA.
All documents and other content published by the European Medicines Agency (EMA) on this website are under the copyright and other intellectual property rights ownership of the EMA. Please refer to Legal notice | European Medicines Agency for further information.

Topics